Target intelligence / Profile preview

LIM domain only protein 7 (LMO7)

Target
LMO7
Molecular classification
Adapter/scaffolding protein, Cytoskeletal-associated protein, Transcriptional regulator, PDZ-LIM protein family, Zinc finger protein (LIM domain), F-box domain protein, Other
01

Overview

LIM domain only protein 7 (LMO7) is a large, multifunctional scaffolding protein characterized by the presence of a LIM domain (a cysteine-rich, zinc-binding motif), a PDZ domain, an F-box domain, a calponin homology (CH) domain, and intrinsically disordered regions[1][2]. LMO7 is predominantly expressed in muscle and cardiac tissues, where it regulates cytoskeletal organization, cell adhesion, and gene transcription[1][2][3]. It is involved in the assembly of protein complexes at cell–cell junctions (notably through E-cadherin and nectin–afadin complexes), modulates actin cytoskeleton dynamics, and participates in the regulation of genes critical for muscle development, such as MyoD and Pax7[1][2][4]. LMO7 shuttles between the nucleus and cytoplasm, functioning in signal transduction between these compartments[2]. Dysregulation of LMO7 contributes to tumorigenesis by promoting cell proliferation, epithelial–mesenchymal transition (EMT), cell migration, and invasion, with roles in diverse cancers and muscular dystrophies[1][2][4]. LMO7 is being investigated as a prognostic marker and potential therapeutic target in cancer, although its pleiotropic cellular roles pose therapeutic challenges[1].

Other names
LIM domain 7FBXO20FBX20KIAA0858LMO-7LMO7bLOMPF-box only protein 20F-box protein Fbx20LIM domain only 7 proteinzinc-finger domain-containing protein
02

Biological functions

Cell adhesionSignal transductionRegulation of cytoskeletonTranscriptional regulationCell growth and differentiationMyogenesis (muscle development)Regulation of nuclear structureCell migration and invasionEpithelial-mesenchymal transition (EMT)Protein complex assembly
03

Disease associations

CancerMuscular dystrophy (specifically Emery–Dreifuss muscular dystrophy)Cardiovascular diseaseNeuromuscular diseaseOther
04

Safety considerations

Targeting multifunctional adaptors like LMO7 may disrupt both normal cytoskeletal and nuclear functions
05

Biomarkers

Prognostic marker in various cancers

Beyond the preview

Go deeper on LIM domain only protein 7 (LMO7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LIM domain only protein 7 (LMO7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call